Basics ABBVIE INC. AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders. IPO Date: December 14, 2012 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $330.3B Activated in VL: True Average Daily Range Avg Daily Range: $0.98 | 1.02% Avg Daily Range (30 D): $2.28 | 1.23% Avg Daily Range (90 D): $2.76 | 1.43% Institutional Daily Volume Avg Daily Volume: 6.32M Avg Daily Volume (30 D): 5.39M Avg Daily Volume (90 D): 5.55M Trade Size Avg Trade Size (Sh.): 108 Avg Trade Size (Sh.) (30 D): 57 Avg Trade Size (Sh.) (90 D): 58 Institutional Trades Total Inst.Trades: 60,543 Avg Inst. Trade: $9.48M Avg Inst. Trade (30 D): $24.19M Avg Inst. Trade (90 D): $23.76M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 19 Market Closing Trades Avg Closing Trade: $87.64M Avg Closing Trade (30 D): $213.83M Avg Closing Trade (90 D): $240.82M Avg Closing Volume: 796.53K     News Jun 5, 2025 @ 1:00 AM CEREVEL ALERT: Bragar Eagel & Squire, P.C. is Inve... Source: Bragar Eagel & Squire, P.C. Jun 4, 2025 @ 5:00 PM Contact The Gross Law Firm by June 3, 2025 Deadlin... Source: The Gross Law Firm Jun 2, 2025 @ 12:21 PM Meta, JPMorgan, Gap And A Health Care Stock On CNB... Source: Avi Kapoor May 29, 2025 @ 9:42 AM Drug Device Combination Products Market Analysis R... Source: Na May 28, 2025 @ 7:27 PM CERE DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Enco... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $.72 $.88 Diluted EPS $.72 $.88 Revenue $ $ 13.34B $ 14.46B Gross Profit $ $ 9.34B $ 10.25B Net Income / Loss $ $ 1.29B $ 1.56B Operating Income / Loss $ $ 3.73B $ 3.83B Cost of Revenue $ $ 4B $ 4.21B Net Cash Flow $ $ -349M $ -5873M PE Ratio